Strive Financial Group »

Novo Nordisk A/S shares owned by Strive Financial Group

Quarter-by-quarter ownership of Novo Nordisk A/S (NVO) shares owned by Strive Financial Group from 13F filings

Historical chart of Strive Financial Group investment in Novo Nordisk A/S

Tip: Access up to 7 years of quarterly data

All positions including Novo Nordisk A/S held by Strive Financial Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Novo Nordisk A/S by Strive Financial Group

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.0M 28k 36.75
2025-12-31 $1.5M 29k 50.88

More positions owned by Strive Financial Group

Call Nvidia Corp $150 Exp 05/15/26 Option Equity Call Option (NVDA)
Call Eli Lilly And Co $800 Exp 05/15/26 Option Equity Call Option (LLY)
Call Alphabet Inc $315 Exp 05/15/26 Option Equity Call Option (GOOG)
Call Taiwan Semiconducto$270 Exp 07/17/26 Option Equity Call Option (TSM)
Vanguard S&p 500 Etf Uit Exchange Traded (VOO)
Ishares Core Msci Eafe Etf Uit Exchange Traded (IEFA)
Vanguard Mid-cap Index Fund Etf Shares Uit Exchange Traded (VO)
Call Amazon.com Inc $217.5 Exp 04/17/26 Option Equity Call Option (AMZN)
Apple Common Stock (AAPL)
Call C H Robinson Worldw$135 Exp 08/21/26 Option Equity Call Option (CHRW)
Meta Platforms Inc Class Class A Common Stock (META)
Alphabet Inc Class Class A Common Stock (GOOGL)
Call The Coca-cola Co $70 Exp 04/17/26 Option Equity Call Option (KO)
Ishares Core U.s. Aggregate Bond Etf Uit Exchange Traded (AGG)
Call Donaldson Inc $80 Exp 05/15/26 Option Equity Call Option (DCI)

View all positions for Strive Financial Group

Top funds holding Novo Nordisk A/S

Citadel Advisors
Loomis, Sayles and
Susquehanna International
Franklin Resources
Jane Street
Capital Research and Management Company - Division 3
Morgan Stanley
Bank of America Corporation
FMR
UBS Group
D. E. Shaw & Co
Folketrygdfondet
Fisher Investments
Two Sigma Investments
Everett Harris & Co

View all funds holding Novo Nordisk A/S